Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective study.

Cancer Med · 2021 · PMC8683525 · PMID 34816617

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In terms of treatment‐related complications, the rates of infections, stomatitis, thrombotic complications, and febrile neutropenia were higher in the DA‐EPOCH‐R group, but the difference did not reach statistical significance (Table 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.